Complementary exams in the diagnosis of American tegumentary leishmaniasis
- PMID: 25184908
- PMCID: PMC4155947
- DOI: 10.1590/abd1806-4841.20142389
Complementary exams in the diagnosis of American tegumentary leishmaniasis
Abstract
The diagnosis of American Tegumentary Leishmaniasis is a difficult but essential task when considering the high toxicity profile of the drugs available. Since the discovery of its etiologic agent, numerous diagnostic tests have been developed. None of the tests available today can be considered as the gold standard, since they do not add enough accuracy for the disease detection. Good epidemiological and clinical knowledge of the disease are fundamental precepts of the dermatology practice and precede the rational use of existing diagnostic tests. In this article we aim, through extensive literature review, to recall fundamental concepts of any diagnostic test. Subsequently, based on this information, we will weave important comments about the characteristics of existing diagnostic tests, including immunological tests such as Montenegro's skin test, serology and detection of parasites by direct examination, culture or histopathology. Finally we will discuss the new technologies and options for the diagnosis of Cutaneous Leishmaniasis. The molecular biology technique is considered a promising tool, promoting the rapid identification of the species involved. We also aim to educate dermatologists about a disease with high morbidity and assist in its difficult recognition.
Conflict of interest statement
Conflict of Interest: None.
Figures












Similar articles
-
Efficiency of noninvasive sampling methods (swab) together with Polymerase Chain Reaction (PCR) for diagnosing American Tegumentary Leishmaniasis.Rev Inst Med Trop Sao Paulo. 2017 Jun 1;59:e38. doi: 10.1590/S1678-9946201759038. Rev Inst Med Trop Sao Paulo. 2017. PMID: 28591266 Free PMC article.
-
Accuracy of diagnostic tests for American tegumentary leishmaniasis: a systematic literature review with meta-analyses.Trop Med Int Health. 2020 Oct;25(10):1168-1181. doi: 10.1111/tmi.13465. Epub 2020 Aug 10. Trop Med Int Health. 2020. PMID: 32677284
-
A proteomic road to acquire an accurate serological diagnosis for human tegumentary leishmaniasis.J Proteomics. 2017 Jan 16;151:174-181. doi: 10.1016/j.jprot.2016.05.017. Epub 2016 Jun 1. J Proteomics. 2017. PMID: 27262223
-
The use of polymerase chain reaction to confirm diagnosis in skin biopsies consistent with American tegumentary leishmaniasis at histopathology: a study of 90 cases.An Bras Dermatol. 2011 Sep-Oct;86(5):892-6. doi: 10.1590/s0365-05962011000500005. An Bras Dermatol. 2011. PMID: 22147028
-
Place of Serology in the Diagnosis of Zoonotic Leishmaniases With a Focus on Visceral Leishmaniasis Due to Leishmania infantum.Front Cell Infect Microbiol. 2020 Feb 25;10:67. doi: 10.3389/fcimb.2020.00067. eCollection 2020. Front Cell Infect Microbiol. 2020. PMID: 32158704 Free PMC article. Review.
Cited by
-
Meglumine antimoniate was associated with a higher cure rate than liposomal amphotericin B in the treatment of American tegumentary leishmaniasis: A retrospective cohort study from a Leishmania braziliensis-endemic area.Front Cell Infect Microbiol. 2022 Sep 23;12:993338. doi: 10.3389/fcimb.2022.993338. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 36211958 Free PMC article.
-
A retrospective cohort study of the effectiveness and adverse events of intralesional pentavalent antimonials in the treatment of cutaneous leishmaniasis.Int J Parasitol Drugs Drug Resist. 2020 Dec;14:257-263. doi: 10.1016/j.ijpddr.2020.11.002. Epub 2020 Nov 19. Int J Parasitol Drugs Drug Resist. 2020. PMID: 33285343 Free PMC article.
-
Accuracy of mucocutaneous leishmaniasis diagnosis using polymerase chain reaction: systematic literature review and meta-analysis.Mem Inst Oswaldo Cruz. 2015 Apr;110(2):157-65. doi: 10.1590/0074-02760140280. Epub 2015 Mar 31. Mem Inst Oswaldo Cruz. 2015. PMID: 25946238 Free PMC article.
-
Use of the polymerase chain reaction for the diagnosis of American tegumentary leishmaniasis.An Bras Dermatol. 2019 Jan-Feb;94(1):113-114. doi: 10.1590/abd1806-4841.20197929. An Bras Dermatol. 2019. PMID: 30726480 Free PMC article. No abstract available.
-
Development of a chimeric protein based on a proteomic approach for the serological diagnosis of human tegumentary leishmaniasis.Appl Microbiol Biotechnol. 2021 Sep;105(18):6805-6817. doi: 10.1007/s00253-021-11518-1. Epub 2021 Aug 25. Appl Microbiol Biotechnol. 2021. PMID: 34432132
References
-
- do Vale ECS, Furtado T. Tegumentary leishmaniasis in Brazil: a historical review related to the origin, expansion and etiology. An Bras Dermatol. 2005;80:421–428.
-
- de Lima EB, Porto C, da Motta JOC, Sampaio RNR. Treatment of American cutaneous leishmaniasis. An Bras Dermatol. 2007;82:111–124.
-
- de Lima MVN, de Oliveira RZ, de Lima AP, Cerino DA, Silveira TGV. American cutaneous leishmaniasis with fatal outcome during pentavalent antimoniate treatment. An Bras Dermatol. 2007;82:269–271.
-
- Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Vigilância Epidemiológica . Manual de Vigilância da Leishmaniose Tegumentar Americana. 2 ed. Brasília: Ministério da Saúde; 2007. 182p
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical